Join Shawna Kraft, PharmD, BCOP, from the University of Michigan Comprehensive Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Series on the topic New and Emerging Treatment Options for Melanoma.

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens.

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.

This information was originally presented at the NCCN 2017 Oncology Fellows Program: New Horizons in Quality Cancer Care™ held on March 26, 2017.

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.